Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase Ib |
| Species: | Human |
| Stage: | Follow up complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A randomized, placebo-controlled, partially blinded Phase 1b clinical trial to evaluate the safety and immunogenicity of BCG revaccination, H4:IC31, and H56:IC31 in healthy, HIV-1 uninfected adolescent participants
Description
HVTN 602 (AERAS A-042) is a Phase Ib clinical trial to evaluate the safety and immunogenicity of vaccine regimens using of BCG revaccination, H4:IC31, and H56:IC31.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.